• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Ionis headquarters
Pharma

FDA approves transformational expansion of Ionis’ Tryngolza

Ionis has gained a transformational FDA expansion for Tryngolza to become the first treatment to reduce the risk of acute pancreatitis that accompanies severe hypertriglyceridemia.
Kevin Dunleavy Jun 25, 2026 8:13am
Beyond China and Japan How biopharma is expanding rare disease access across Asia-Pacific

Beyond China and Japan: How biopharma is expanding rare disease access across Asia-Pacific

Brought to you by DKSH
Supreme Court building in Washington DC

SCOTUS ruling blunts state-level claims against Bayer's Roundup

Jun 25, 2026 1:52pm
The legacy approach to real-world data is costing you

The legacy approach to real-world data is costing you

Brought to you by HealthVerity
FDA

FDA finds fault with Pinnacle’s photodynamic therapy videos

Jun 25, 2026 10:12am
Four large while puzzle pieces are being connected together on a dark brown table by four sets of hands

Merck KGaA charts biggest deal in 10+ years with Bio-Techne buy

Jun 25, 2026 9:56am
More News

AstraZeneca spells out a cancer screening strategy with the YMCA

Jun 25, 2026 4:30am

Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC

Jun 24, 2026 5:00pm
Fierce Biotech

Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO

Jun 24, 2026 3:03pm

FDA approves breast cancer expansion for Pfizer's Ibrance

Jun 24, 2026 2:48pm
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings